University Medical Centre Utrecht
Valentijn Schweitzer (1987) is part of the research group of prof. Marc Bonten and a resident in Clinical Microbiology at the University Medical Centre Utrecht. He graduated as a Medical Doctor in 2014 and completed a MSc degree in Epidemiology in 2018. Since 2014 he is working as a PhD candidate on the subject of Antimicrobial Stewardship and Community-acquired Pneumonia with a special interest in research design and methodology.
National laboratora for health, environment and food, NLZOH and University of Maribor, Faculty of Medicine, Maribor, Slovenia
Prof. Maja Rupnik is head of Department for microbiological research at National laboratory for health, environment and food (NLZOH) in Maribor, Slovenia. She is also a Professor for Microbiology at Faculty of Medicine, University of Maribor. She is a worldwide recognized expert on Clostridium difficile. Her research interest is focused on molecular epidemiology of Clostridium difficile, molecular typing techniques and gut microbiota. The main interest of her group are the variant C. difficile strains and abiotic reservoirs of C. difficile.
The honors and awards she obtained for her work include Alexander von Huboldt grant, ESCMID/bioMerieux Award for Advances in Clinical Microbiology and national Zois award for exceptional scientific achievements in microbiology. She is also the president of the traditional event ICDS, International C. difficile Symposium (www.icds.si).
European Centre for Disease Prevention and Control (ECDC)
Dr Diamantis Plachouras is an infectious diseases physician with experience in clinical infectious diseases, infection control and antimicrobial stewardship. Since 2012, he has been a member of the surveillance and response support unit of the European Centre for Disease Prevention and Control (ECDC) in the Disease Programme for antimicrobial resistance and healthcare associated infections (ARHAI). His key activities have included surveillance of and response to healthcare-associated infections and antimicrobial resistance in Europe, the development of guidelines on the prudent use of antimicrobials in human medicine and the development of indicators of antimicrobial stewardship. He received his medical diploma in 1994 and a doctorate degree in Medicine at the University of Athens, Greece. He specialised in internal medicine in the UK and Greece and subsequently in infectious diseases and worked from 2006 until 2012 as a lecturer and assistant professor at the “Attikon” hospital of the University of Athens in Greece.
University of Maryland and Baltimore VA Medical Center
Daniel Morgan MD, MS is a physician and epidemiologist in Baltimore, Maryland. He is Associate Professor of Epidemiology and Medicine at the University of Maryland School of Medicine, Chief Hospital Epidemiologist at the Baltimore VAMC and a fellow at the Center for Disease Dynamics, Economics and Policy (CDDEP). His research explores infection prevention and medical overuse. This includes pragmatic issues related to the control of infectious diseases in the hospital and patient safety, including the best use of patient isolation, automated methods for hand hygiene compliance, prevention of MRSA and carbapenem-resistant Enterobacteriaceae (CRE), the importance of the environment on transmission of bacteria, multicenter infection prevention studies and antimicrobial stewardship. He was a founding member and past Director of the Society for Healthcare Epidemiology of America (SHEA) Research Network and is on the Board of Directors of SHEA.
On a NIH New Innovator award for “exceptional scientists pursing highly innovative approaches to major challenges” he is exploring how poor clinician understanding of risk leads to medical overuse.
His work is funded through the US NIH, CDC and AHRQ.
Bichat – Claude Bernard Hospital, Paris, France
Jean-Christophe LUCET is a Professor in Microbiology and Infection Control. He is head of the Infection Control Unit of the Bichat – Claude Bernard University Hospital in Paris, France. His research interests are the epidemiology and control of multiply-resistant bacteria in the hospital setting (ESBL, MRSA and highly-resistant bacteria) using intervention tools, behavioral approach and statistical modeling.
Other research topics include new techniques for assessing infectious risk and interaction between patients and healthcare workers; behavioral approach of Infection control; methodological aspects of surveillance and reporting of surgical site infection; and prevention of healthcare-associated infection (HAI) in the ICU.
Besides hospital and research activities, he participates to French and European expert groups, including in France : quality indicators to be publicly reported in French healthcare institutions, updating definition of HAI and recommendations for prevention of various conditions, including multiply- and highly-resistant bacteria, and recently reorganisation of national networks for surveillance and prevention.
Charité Universitätsmedizin Berlin
Rasmus Leistner (MD, PhD) is board-certified in infection control and hospital epidemiology. His main interests are infectious diseases epidemiology (e.g. ESBL, PVL-S. aureus) and antibiotic stewardship. He studied medicine in Germany, U.S.A. and Canada and then conducted his training at the Institute of Hygiene and Environmental Medicine, Charité Universitätsmedizin, Berlin and the National Reference Center for the Surveillance of Nosocomial Infections. Since 2017, he is associated professor for infection control and hospital epidemiology. He is currently vice chairperson of the section infection prevention and antibiotic resistance in hospital hygiene of the German Society for Hygiene and Microbiology (DGHM).
University of Iowa Carver College of Medicine
Dr. Herwaldt is a Professor in Internal Medicine/Infectious Disease at the University of Iowa Carver College of Medicine. She has a joint appointment in the Epidemiology Department of the College of Public Health. She is board certified in Internal Medicine and Infectious Disease. Dr. Herwaldt does infectious diseases consults and she conducts research related to healthcare-associated infections and prevention of pathogen transmission to patients and healthcare workers. She has grants from the Centers for Disease Control and Prevention and the Agency for Healthcare Research and Quality.
Dr. Herwaldt previously, served as the Hospital Epidemiologist at the University of Iowa Hospitals and Clinics for 20 years, after having served as the Associate Hospital Epidemiologist for five years.
Dr. Herwaldt is on the Planning Committee for the International Conference on Prevention and Infection Control and she previously served on the Planning Committee for the Interscience Conference on Antimicrobial Agents and Chemotherapy. She has served in various capacities for the Society for Healthcare Epidemiology of America (SHEA): member and of chair of the SHEA Nomination Committee, member of SHEA the Education Committee, and the External Affairs Committee, Treasurer, and Academic Counselor. She edited the first edition of the Practical Handbook for Healthcare Epidemiologists.
Dr. Herwaldt received her bachelor’s degree in chemistry from Grinnell College and her doctor or medicine degree from the University of Wisconsin School of Medicine. She completed a residency in internal medicine at Barnes Hospital in St. Louis and an infectious disease fellowship at Washington University in St. Louis. Between her residency and fellowship, she served as an Epidemic Intelligence Service Officer at the Centers for Disease Control and Prevention for two years. She received the SHEA Young Investigator Award and the SHEA Mentor-Scholar Award.
Department of Infection Control and Hospital Hygiene, Stockholm and Division of Infectious Diseases, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
Susanne Wiklund became a Registered Nurse in 1980. She’s a Nurse specialist in intensive care, anesthetics and primary health care. Susanne is working as an Infection Control Nurse at the Department of Infection Control and Hospital Hygiene in Stockholm, Sweden. She has a Diploma in Infection Control and a Master of Public Health. She is also a researcher at the Division of Infectious Diseases at Karolinska Institutet, Solna, Sweden. Her Doctoral dissertation took place in 2015 with the thesis “Carriage of ESBL (Extended Spectrum Beta-lactamases) -producing bacteria – knowledge, emotional impact and risk assessment”. Her research area concerns the human perspective and consequences of a carriership of ESBL. The studies highlight in what ways antibiotic-resistant bacteria affects different groups in the population – citizens, patients and healthcare staff.
Radboud University Nijmegen Medical Centre
In 2003, Professor Andreas Voss became the first professor of infection prevention in the Netherlands. His research focuses on improving infection prevention and hygiene in hospitals. He specializes in the epidemiology and prevention of multi-resistant hospital bacteria, such as MRSA, VRE, ESBL en CPE. He is particularly interested in hand hygiene, especially in replacing hand washing and introducing bedside disinfection of the hands.
Voss wishes to show to the new generation of doctors and nurses that infection prevention has a major impact on the quality of health care. Patient care and education, therefore, are his priorities. He closely collaborates with other departments within the Radboud university medical center and with other national and international working groups/societies. His is presently chair on WIP’s expert group on infection control in nursing homes.
By continuing to browse this website you are agreeing to accept cookies used to provide a more personalized experience, generate statistics and facilitate targeted website or social network advertising. You can change your cookie settings at any time. Find out more about our Privacy & Cookie policy and how to manage browser cookies: more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.